Chow, Laura Q M <br/><br/>
Exploring novel immune-related toxicities and endpoints with immune-checkpoint inhibitors in non-small cell lung cancer.  [electronic resource] 

 -  American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting  2013 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Video-Audio Media 
<br/><br/><label>ISSN: </label>1548-8756 
<br/><br/><label>Standard No.: </label>10.14694/EdBook_AM.2013.33.e280  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Apoptosis--drug effects<br/>B7-H1 Antigen--antagonists & inhibitors<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Humans<br/>Immunotherapy--adverse effects<br/>Lung Neoplasms--drug therapy<br/>Lymphocyte Activation--drug effects<br/>Molecular Targeted Therapy--adverse effects<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Risk Factors<br/>Signal Transduction--drug effects<br/>Treatment Outcome